Suboxone
Every registration of this product has been cancelled.
(4R,4AS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5284596.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Suboxone 2 MG EACH SUBLINGUAL TABLET CONTAINS: BUPRENORPHINE HYDROCHLORIDE EQUIVALENT TO BUPRENORPHINE 2,0 mg, NALOXONE HYDROCHLORIDE EQUIVALENT TO NALOXONE 0,5 mg | 2 mg | 41101041/34/1010 | Cancelled | Not determined | PIPIL |
| Suboxone 8 MG EACH SUBLINGUAL TABLET CONTAINS :BUPRENORPHINE HYDROCHLORIDE EQUIVALENT TO BUPRENORPHINE 8,0 mg, NALOXONE HYDROCHLORIDE EQUIVALENT TO NALOXONE 2,0 mg | 8 mg | 41101141/34/1011 | Cancelled | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Buprenorphine
Consolidated Schedules 06 July 2026, line 10099
S6: Oxycodone
Consolidated Schedules 06 July 2026, line 10363
S4: Naloxone
Consolidated Schedules 06 July 2026, line 7206
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.